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Abstract
The use of Complementary and Alternative Medicine (CAM) among cancer patients is widespread
and appears to be increasing. However, it is not clear whether patients use CAM as an 'alternative'
to standard oncology care or as an adjunct to the conventional treatment they receive. This study
reviews the role of CAM therapies in the management of cancer, from the view of both patients
and health professionals and it highlights issues relating to the efficacy of CAM used by cancer
patients. Most patients use CAM to 'complement' the conventional therapies of radiotherapy,
chemotherapy, hormone therapy and surgery. Health professionals in general have expressed
positive views when CAM is used 'complementarily' and not as an 'Alternative'. Results so far
published have shown that CAM can contribute to improving the quality of life of cancer patients
and their general well-being.
Background
Many cancer patients have turned to Complementary and
Alternative Medicine (CAM) with the hope of finding a
cure to their illness as well as to make them feel better.
Surveys on the use of CAM by cancer patients have been
reported as high as 64% and as low as 7% [1]. As the use
of CAM with cancer patients increases, the concern for its
efficacy and safety with cancer patients has also increased
[2,3]. In spite of the mass use of CAM therapies, very little
is known of the efficacy and safety of many of the CAM
therapies that cancer patients use.
Complementary and alternative medicine 
(CAM)
Complementary and Alternative Medicine (CAM) is
defined by the Cochrane collaboration as:" a broad
domain of healing resources that encompasses all health
system, modalities, and practices and their accompanying
theories and beliefs, other than intrinsic to the politically
dominant health systems of a particular society or culture
in a given historical period" [4]. However, the National
Centre for Complementary and Alternative Medicine
(NCCAM 2006) in America defines CAM as "a group of
diverse medical and health care systems, practices and
products that are not presently considered to be part of
conventional medicine" [5]. The definition given by
Cochrane emphasises healing resources together with its
beliefs and theories, while NCCAM talks about systems,
practices and products outside conventional medicine. A
more recent definition of CAM adapted by the Cochrane
School of Complementary medicine is: " diagnosis, treat-
ment and/or prevention which complements main stream
medicine by contributing to a common whole, by satisfy-
ing a demand not met by orthodox methods or by diver-
sifying the conceptual framework of medicine". Ernst and
Cassileth favour this definition because it sees CAM as
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"complementary" to conventional medicine [1]. The
World Health Organisation (WHO) defines CAM as: "A
comprehensive term used to refer to both traditional med-
ical systems such as traditional Chinese medicine, Indian
ayurverda, Arabic unani medicine, and to various forms of
indigenous medicine" [6].
The term Complementary and Alternative Medicine
(CAM) is an umbrella term covering both 'complemen-
tary therapies' and 'alternative medicines'. Though the
phrases are sometimes used synonymously, differences
exist between the two. The phrase 'complementary ther-
apy' is defined by cancerBacup as "treatments which are
given alongside the conventional cancer treatments" [7].
This means it is there to complement the main conven-
tional therapies such as radiotherapy, surgery, hormone
treatment and chemotherapy in the case of cancer
patients. The phrase 'Alternative medicine' is described as
"practices used instead of standard medical treatment"
[8]. However, the definition of "Alternative medicine"
outlined by World Health Organisation (WHO) encom-
passes all forms of healthcare provision, which usually lie
outside the official health sector. This definition makes no
distinction between the terms "Alternative" and "Comple-
mentary". Therefore, in the case of cancer management,
anything that falls outside radiotherapy, surgery, hor-
mone therapy and chemotherapy could be considered as
Alternative medicine. Because of the meaning attached to
the phrase "Alternative therapy", most people prefer to
use the term "complementary" instead, although the term
is still used to differentiate natural medicine from modern
medicine [9]. Nonetheless, the term "Alternative medi-
cine" is popular and much preferred in the United States,
as most people still believe that it can sometimes replace
conventional medicine in cases where conventional med-
icine has not lived to expectations [10].
Defining what complementary and alternative medicine
(CAM) is, has not been without difficulties. One such
problem lies in the fact that there is no clear-cut definition
of CAM. What is considered as complementary in the UK
is in fact conventional in another country. For instance,
Lewith explains that herbal medicine and acupuncture are
practiced as Complementary therapy in UK and USA
whereas they are considered as part of the main conven-
tional medicine in China [11].
According to CancerBacup, CAM can be divided into three
different categories. These are psychological and self-help
therapies, which help patients, deal with the emotional
and psychological aspects of their illness like stress, anxi-
ety and depression. Among these therapies are counsel-
ling, relaxation, healing, visualisation, meditation and art
therapy and hypnotherapy. The second group of comple-
mentary therapies are considered as physical therapies.
These therapies use the sense of touch as the main tool
and among them are aromatherapy, acupuncture, mas-
sage, reflexology and shiatsu. The last group of comple-
mentary therapies are those classified as unconventional
medicine or drugs, and includes Homeopathy, Herbal
medicine, Essiac, and Bach flower remedies.
However, Montbriand in his study on the overview of
complementary therapies chosen by cancer patients had a
different grouping for complementary therapies, and
described the three types of CAM as psychological, physi-
cal and spiritual [12]. The psychological therapies involve
some kind of distraction strategies to take the mind of
patients off the illness with a positive attitude towards life
and finally cure. The physical therapies include herbal tea
treatment, injection of thyme enzyme for the enhance-
ment of the immune system, diet alteration and megavita-
mins. Spiritual therapies involve prayer and healing, for
example.
It has been argued that Complementary and Alternative
Medicine emphasises the healing of both body and mind.
According to Herzberg "While scientific medicine focuses
on cures of diseases, complementary medicine is con-
cerned with helping us to heal ourselves" [9] Similarly
Fulder, considers that complementary therapy emphasises
the restoration of health rather than the removal of sick-
ness [10]. Tschudin, points out that attitude is one of the
fundamental differences between complementary thera-
pies and orthodox medicine [13]. While orthodox or con-
ventional medicine views symptoms as hostile and treats
them accordingly, Tschudin considers that complemen-
tary therapies "use a symptom of illness which a person
presents merely as a tool, guide or instructor, to discover
more basic imbalances in the person's body, mind or
spirit".
The prevalence of CAM use among cancer 
patients
There has been a steady increase in the use of complemen-
tary and alternative medicine among cancer patients for
the past decades [14]. Among the early studies to ascertain
the level of CAM use among cancer patients, Downer et al,
reported that 16% of cancer patients surveyed in two hos-
pitals in London admitted to using CAM. [15]. This figure
is similar to an earlier report in which CAM use was
reported at 13% in the USA [16]. However, a recent survey
of 127 cancer patients in the UK reported that 29% of
their sampled population were using some form of CAM.
[17]. In a systematic review of surveys on the use of CAM
among cancer patients in 13 countries, Ernst and Cassileth
reported a range of 7% to 64% of CAM use among the
adult cancer population and the average of 31.4% across
all the studies [1]. Some of the commonly used CAM
included visualisation, herbs, dietary treatment, medita-International Seminars in Surgical Oncology 2007, 4:10 http://www.issoonline.com/content/4/1/10
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tion, relaxation, homeopathy, hypnotherapy and other
mega vitamins. The data collection method used in indi-
vidual studies was either by interviewing the patients or
sending out questionnaires or both. Nine out of the
twenty-six surveys were conducted by means of interview-
ing the patients, fifteen were through questionnaire and
two of them employed both methods. The prevalence rate
among the nine surveys conducted through interview
ranged between 7% and 37% with only one recording a
rate of 54% of which spiritual healing was part of the
treatment specified. The fifteen other surveys conducted
by means of questionnaire reported a prevalence rate of
between 16% and 64%. A survey in 14 European coun-
tries on the use of CAM among patients with haematolog-
ical cancers showed that 36% of cancer patients in Europe
have used one or more forms of CAM modalities[18].
Similarly, a rate of 40% was reported in the USA after a
cross-sectional study of 1904 patients who have previ-
ously been diagnosed with cancer [19]. A 2002 National
Health Interview survey was used in this study. The most
popular CAM therapies used were herbal medicine, deep
breathing and meditation. An earlier study conducted in
the United States produced a similar prevalence rate of
42% [20]. A survey conducted in Canada reported a 43%
prevalence rate of CAM use among cancer patients [21]. In
New Zealand, a rate of 49% among 200 cancer patients
was reported [22]. The most prominent of the therapies
were Vitamins (68%) and Antioxidants (54%).
A similar result was found in Japan, that found use among
44.6% of 3,100 cancer patients [23]. However, 96.2% of
the patients were using products such as Chinese herbs,
mushroom, shark cartilage and vitamins, which would be
considered as CAM products in the west. This emphasises
the problem with interpreting some of these data, as the
reported varying prevalence rate of CAM use among can-
cer patients across different surveys has been attributed to
the lack of consistency in the definition of CAM and its
specificity with regard to what can be considered as a CAM
modality [24]. For example, Mao et al included prayer as
a CAM modality [19], while others like Harris et al [24]
and Scott et al [17] did not. Mao et al reported that over
61% of patients in his study relied on prayer as a form of
CAM therapy for their cancer [19]. This is in contrast with
a report which mentioned meditation and relaxation as
the most commonly used CAM modality [2]. However,
the exclusion of prayer from the patients' questionnaire
could be a factor. In a study in the UK, aromatherapy and
relaxation techniques were among the most popular CAM
therapies used by cancer patients [11]. This is clearly in
contrast to a survey where herbal medicines were reported
to be the most commonly used therapy [18].
Despite these inconsistencies, the socio-demographic pat-
tern of CAM use reveals some consistencies across most of
the studies conducted on CAM use among cancer patients.
The main recurring themes through out most of the stud-
ies were that those who were most likely to use CAM were
female, married people, higher earners, better educated
and those who have used CAM before their diagnoses
[25]. In a study to assess the patterns of alternative medi-
cine use by 319 cancer patients in Australia discovered
that most of the patients who employed CAM as part of
their cancer management were women (55.5%), people
who were married (67.2%) and those with private health
insurance (55.2%) [26]. This was consistent with the
study carried out in Japan, which had women as the high-
est single users of CAM modalities in their study of 3100
cancer patients [23]. In the study by Downer et al, 52% of
the sample population who have admitted using a form of
CAM were women, while 64% of the patients using com-
plementary therapy were married [15]. The study con-
ducted by Molassiotis et al on CAM use among patients
with haematological malignancies had 76% of the study
sample as married, and over half of sample was women as
well [18]. These results may reflect the fact that breast can-
cer patients are the most likely group to use CAM thera-
pies [15,21,24].
Patients reasons for using CAM
As more cancer patients turned to CAM in their quest to
find a cure for their illness or to better their quality of life,
the need to understand their views or perceptions of CAM
is of interest. Ernst explained that the reasons given by
patients for their use of CAM could be grouped into push
factors (negative) which pushes patients away from con-
ventional medicine and pull factors (positive) which
relates to the positive aspects of CAM which makes it
attractive to patients [27]. Among the push factors are dis-
satisfaction with conventional medicine, the perceived
"poor relationship" with some health care professionals,
and desperation on the part of patients to get cured [28].
Hope for a positive outcome of a treatment was men-
tioned as among some of the positive factors in addition
to patients hope for a control over their treatment [2].
Ernst also mentions that good rapport between patients
and therapist, as well as the ease at which one can access
a CAM modality is a determining factor for patients' use
of CAM. These reasons reflect those given by patients in
various studies [1,15,17]. Prominent among these were
the urge to take control of the treatment and to improve
their general condition. In a Norwegian study conducted
to ascertain the reasons behind cancer patients' use of
non-proven complementary therapies, 36% of 104
patients who participated reported actual improvement in
their general condition [29].
The perceptions of patients regarding the use of CAM have
been at the centre of discussions whether it is used as an
'alternative' to standard oncology treatments of radiother-International Seminars in Surgical Oncology 2007, 4:10 http://www.issoonline.com/content/4/1/10
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apy, surgery and chemotherapy or to 'complement' the
conventional treatments [30]. Regardless of whether
patients use CAM as an 'Alternative' or 'Complementary'
to conventional medicine, they perceive it as a very 'natu-
ral therapy' and 'harmless'. In a study by Ponholzer et al
on the frequent use of complementary medicine by pros-
tate cancer patients, 90% of the patients were reported to
have used CAM with the aim to improve their quality of
life [31]. This view is supported by Roberts et al [32] as
well Kaasa [33]. In a Norwegian survey, it was reported
that most patients were using CAM as it might give them
strength to go through the conventional therapies and
help to relieve their symptoms [29]. Molassiotis et al con-
ducted a descriptive cross-sectional survey on 127 colorec-
tal cancer patients across seven European countries [18].
Over 47% of the patients reported using CAM with the
view of increasing the body's ability to fight off the disease
while just fewer than 45% of patients believed that CAM
could help improve their physical well-being. In a study
by Begbie et al, the most common reason for CAM use was
a new hope for cure (49%) and preference for 'natural
therapy' was about 20% [26]. Psychological distress was
mentioned by Ernst and Fugh-Berman [34] and Holland
[35] as among the popular reasons for patients using
CAM. In a study on CAM use by cancer patients in Wales,
patients cited pain relief as the main reason for using
CAM. [24].
Despite the fact that more and more cancer patients are
turning to CAM modalities for a number of reasons, few
patients disclose this to their health care professionals
[32,36]. Studies so far conducted by indicated that just
about half of the cancer patients who use CAM inform
their doctors of such use [15,25]. Patients perceive a lack
of interest on the part of health care professionals or their
total disapproval of the therapies [37]. The lack of com-
munication about CAM between patients and health pro-
fessionals limits the opportunity to discuss the potential
benefits and risk of the therapies.
Efficacy and safety
There has been very little in the way of scientific research
into Complementary and Alternative Medicine used by
cancer patients in spite of the apparent extensive use of
CAM. [38,39]. One of the criticisms levelled against CAM
is its' lack of "peer-reviewed scientifically conducted
research" as pointed out by the American Society of Clin-
ical Oncology. Several factors have been cited for this.
Vickers, including lack of funding and insufficient patient
numbers for a study [40]. Hilsden and Verhoef explained
that evidence pertaining to the effectiveness of CAM is
vital in the decision making of government regarding
whether it should be administered or not [41]. Clinical tri-
als are needed to help evaluate and ascertain the benefits
of CAM. Randomised control trials (RCT) have been used
as the golden rule in evaluating the effectiveness of a med-
ical intervention and reliable evidence in the form of sys-
tematic reviews and meta-analyses regarding safety and
efficacy are also important [42]. Some Health care profes-
sionals in the UK are of the view that for CAM to be
accepted as part of the services rendered by the NHS, it
should be judged by the same yardstick as any conven-
tional medicine [43]. However, there is the opinion that
quality of life and feeling of hope among patients should
be included [44]. Most CAM modalities are based on
beliefs, practices and traditions of a culture and not on sci-
entific knowledge and their potential benefits and effec-
tiveness based on experiences or testimonials of patients.
It has been reported in various studies that patients have
used multiple CAM modalities in addition to a conven-
tional treatment, and this has made it difficult to deter-
mine the potency of each single modality [45,46].
In a systematic review of Randomised control trials on
CAM use by breast cancer patients, Ernst et al identified
fifteen studies[47]. Fourteen of the studies used CAM as
an adjunct to standard oncology care and only one used
the CAM as a sole therapy. Different therapies were tested
ranging from psychological and psychosocial support,
herbal remedies and massage. It was evident in their
review that none of the modality proved effective as an
alternative to conventional treatment. It was however evi-
dent that some therapies did help patients in terms of
their adjustment to life, such as massage and spiritual
therapy. Smith et al conducted a study on the outcomes of
therapeutic massage for 41 hospitalised cancer patients
and they reported a positive outcome for the study [48].
They compared the outcomes of therapeutic massage on a
group of patients and that of a nurse interaction on a con-
trol group. It was observed that pain, distress, anxiety and
sleep quality was worse in the control group and con-
cluded that therapeutic massage help to alleviate pain,
distress, as well as improving sleeping patterns. Out of 41,
38 (95%) were men, over 89% were Caucasians and were
not in employment. Cassileth and Vickers conducted a
much larger study of massage for cancer patients with a
sample size of 1290 [16]. Majority of the sample were in-
patients (74%), the setting was at the cancer centre for the
in-patients, and the outpatients were treated in their vari-
ous homes. Patients reported over 40% improvement in
their pain and fatigue and over 50% in their anxiety levels.
A study that looked into how 58 cancer patients adjust to
illness when treated with and without CAM in addition to
conventional treatments found that patients treated by
complementary therapy with conventional therapy fared
better psychologically as compared to those treated with
only conventional therapy [49]. This was supported by
other studies which concluded that aromatherapy to some
extent helped improve psychological distress among
patients [50,51]. Most of the studies on aromatherapy soInternational Seminars in Surgical Oncology 2007, 4:10 http://www.issoonline.com/content/4/1/10
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far conducted have proven the benefits to cancer patients
in terms of managing psychological distress and adjust-
ment to life.
However, in cases where CAM has been used solely as an
'alternative' to standard care, the outcome has been very
poor. In a recent study on the outcomes of breast cancer
patients who used alternative therapies as primary treat-
ment, it was discovered that the sole use of CAM as pri-
mary treatment for breast cancer resulted in increased
recurrence and death of patients [52]. Some of the thera-
pies that the patients opted out for included herbal ther-
apy, dietary therapy and high-dose vitamins. A total of 33
breast cancer patients' medical records were reviewed.
These patients initially refused standard oncology care or
delayed their treatment. Some patients developed disease
progression; others had local recurrence while the rest
died of metastatic disease. In 2001 in Netherlands a
patient died of breast cancer after having CAM therapies
instead of conventional therapies [53].
Perceptions of CAM by health professionals
A study on the knowledge and attitude of oncology pro-
fessionals towards CAM reported that oncology profes-
sionals expressed a negative attitude towards alternative
therapies as opposed to complementary therapies [54].
This indicated that health professionals by and large are
less sceptical when CAM is solely used to complement
mainstream oncology treatments rather than it being used
as an alternative. However, the use of CAM as an alterna-
tive to conventional medicine has resulted in a negative
response from health care professional [55]. This reflects
a Korean study to access the knowledge base of both West-
ern and Oriental medical doctors in which more than
50% of Western medical doctors were of the view that
"scientifically unproven treatments should be discour-
aged legally". However, only 11% of the Oriental medical
doctors where in agreement to this view. Most comple-
mentary therapies are unproven and people need to be
cautious of web sites claiming to have alternatives cure for
cancer [38]. In a study on physicians' attitude towards the
use of complementary therapy by cancer patients in Fin-
land, well over 90% of the physicians were of the opinion
that CAM could not wholly cure cancer and therefore
must not be encouraged [55]. This was evident in a report
from the Netherlands when a patient died from breast
cancer after being treated exclusively with various types of
CAM therapies, which included acupuncture, faith heal-
ing, salt therapy and psychic healing at the expense of
radiotherapy and chemotherapy [53]. The fear of patients
abandoning or delaying their conventional cancer treat-
ments that are proven in favour of unproven CAM is a
major concern [57].
Robotin and Penman [58] and Newell [59] pointed out
that the gaps in the knowledge base of healthcare profes-
sionals on CAM played a role in their decision-making
regarding the use of complementary and alternative med-
icine. Most health care professionals have admitted that
they know very little about complementary and alterna-
tive cancer therapies [59]. One study confirmed that most
physicians get their information regarding CAM from
patients [57]. However patients rarely inform their physi-
cians about their CAM use, which therefore limit physi-
cians' knowledge of CAM. [60]. Insufficient or lack of
knowledge on the part of health professionals could be a
factor for the lack of approval for CAM use and the subse-
quent negative attitudes and beliefs [61].
In a survey conducted to assess the familiarity of health
professionals with CAM, 67% of the 214 participants
mentioned hypnotherapy, acupuncture and imaging as
the most familiar of the modalities but would rather rec-
ommend support groups for their patients for managing
cancer pain [62], although studies conducted so far have
shown that health professionals know very little about
Complementary and Alternative medicine CAM they have
shown interest in CAM [62]. Various reasons have been
cited for patients' use of CAM by doctors and other health
professionals. Some health professionals perceive cancer
patients' use of CAM as a way of life [63]. The idea that
'new innovations' have cropped up and most cancer
patients use complementary therapies as a way of living
and therefore it is only normal to access CAM rather than
having thought through its benefits and risks to the indi-
vidual patients. The thought by some women in some
quarters that 'most women' are using essential oils to help
cope with their chemotherapy" had made some women
turn to aromatherapy to satisfy their curiosity.
Some health professionals believed that their patients did
use CAM therapy as a means of changing their way of life.
On the issue of the efficacy of CAM therapies, opinions
expressed by health professional have been relatively pos-
itive. However, the reported efficacies of CAM were
related to the alleviation of side effects to help adjust to ill-
ness rather than cancer cure (Gilbar et al 2001). In a sur-
vey conducted by Ernst et al (1995) to assess the
perception of physicians on CAM effectiveness, 46% of
the physicians perceive CAM as moderately effective. It
was however noted that younger doctors were more likely
to be in favour of CAM compared to the older physician.
The possible explanation to this could be that younger
doctors are more likely to use CAM for themselves or even
recommend it to family members as compared to the
older ones (Cunningham et al 1998, Downer et al 1994 &
Boon et al 2000).International Seminars in Surgical Oncology 2007, 4:10 http://www.issoonline.com/content/4/1/10
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A concern, which is generally shared by most health care
professionals, is the fact that some research carried out has
reported possible interactions between some commonly
prescribed drugs and CAM products (Izzo and Ernst 2001
& Miller 1998). These interactions if any could have seri-
ous effects on the treatment of patients and their subse-
quent recovery. Lack of clear guidelines with regard to
referrals and ultimate responsibility for 'bad outcomes' is
one of the reasons why health professional distant them-
selves from CAM therapies and this makes it difficult to
determine their stance with CAM. [61].
Conclusion
Complementary and Alternative Medicine is an increas-
ingly popular option among cancer patients. However,
lack of clear definitions about what constitutes CAM
makes it difficult to reach clear conclusions about efficacy
and safety. Even so, there is no evidence to suggest that
CAM can replace conventional treatment, and there is a
need for reliable and consistent information to be made
available to patients.
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